This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
PEGASYS
PHARMAAND GMBH
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is PEGASYS discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that PEGASYS 180MCG has been permanently discontinued (last updated January 4, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is PEGASYS not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02248077
Strength
180MCG
Dosage Form
SOLUTION
Route
SUBCUTANEOUS
Active Ingredient
PEGINTERFERON ALFA-2A
Tier
Tier 3 — Critical
Last Updated
2026-10-27
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
PEGASYS has 2 shortage/discontinuation reports on file — this is one of them.